From: Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
Prognostic factors | OS | ||
---|---|---|---|
P value | P value | HR (95Â % CI) | |
(univariate) | (multivariate) | (for multivariate) | |
Sex (male, female) | 0.011 | 0.012 | 1.346 (1.071-1.803) |
Age (≤60, >60 year) | 0.373 |  |  |
Tumor location (upper, middle, lower) | 0.277 | Â | Â |
Tumor length (<5 cm, ≥5 cm) | 0.890 |  |  |
Tumor differentiation (well, moderately, poorly) | 0.148 | Â | Â |
T stage (T1, T2, T3, T4) | 0.128 | Â | Â |
N stage (N0, N1, N2, N3) | <0.001 | <0.001 | Â |
N0 | Â | Â | 1 |
N1 |  |  | 1.875 (1.187–2.962) |
N2 |  |  | 3.646 (2.355–5.645) |
N3 |  |  | 2.444 (1.387–4.307) |
Adjuvant therapy (none, chemotherapy, radiotherapy, chemoradiotherapy, unknown) | 0.027 | Â | Â |
EGFR (≥80, <80) | 0.735 |  |  |
p-EGFR (≥10, <10) | 0.392 |  |  |
AKT1 (≥30, <30) | 0.362 |  |  |
p-AKT1 (≥70, <70) | <0.001 | <0.001 | 2.682 (1.891–3.802) |
AKT2 (>0, =0) | 0.179 | Â | Â |
p-AKT2 (>0, =0) | 0.379 | Â | Â |
ERK1 (≥40, <40) | 0.683 |  |  |
ERK2 (≥70, <70) | 0.558 |  |  |
p-ERK1/2 (≥50, <50) | 0.209 |  |  |
STAT3 (≥50, <50) | 0.233 |  |  |
p-STAT3 (≥30, <30) | 0.621 |  |  |